{"id":"https://openalex.org/W75615743","doi":"https://doi.org/10.1177/030089160909500306","title":"Prognosis of Acute Myeloid Leukemia in the General Population: Data from Southern Switzerland","display_name":"Prognosis of Acute Myeloid Leukemia in the General Population: Data from Southern Switzerland","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W75615743","doi":"https://doi.org/10.1177/030089160909500306","mag":"75615743","pmid":"https://pubmed.ncbi.nlm.nih.gov/19688968"},"language":"en","primary_location":{"id":"doi:10.1177/030089160909500306","doi":"https://doi.org/10.1177/030089160909500306","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089160909500306","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013803774","display_name":"Erika Lerch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Erika Lerch","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070583191","display_name":"Vittoria Guro Espeli","orcid":"https://orcid.org/0000-0001-5374-129X","observed_orcids":["https://orcid.org/0000-0001-5374-129X"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Vittoria Espeli","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102763531","display_name":"Emanuele Zucca","orcid":"https://orcid.org/0000-0002-5522-6109","observed_orcids":["https://orcid.org/0000-0002-5522-6109"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Emanuele Zucca","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103730511","display_name":"Leda Leoncini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Leda Leoncini","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089983320","display_name":"Giancarlo Scali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giancarlo Scali","raw_affiliation_strings":["Centro Trasfusionale CRS, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Trasfusionale CRS, Lugano, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111718802","display_name":"Oreste Mora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Oreste Mora","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107862187","display_name":"Andrea Bordoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152191","display_name":"Istituto Cantonale di Patologia","ror":"https://ror.org/05gkz0v31","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210107434","https://openalex.org/I4210152191"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andrea Bordoni","raw_affiliation_strings":["Registro dei Tumori del Canton Ticino, Locarno, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Registro dei Tumori del Canton Ticino, Locarno, Switzerland","institution_ids":["https://openalex.org/I4210152191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111869822","display_name":"Franco Cavalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Franco Cavalli","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045311601","display_name":"Michele E. G. Ghielmini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michele Ghielmini","raw_affiliation_strings":["Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]},{"raw_affiliation_string":"Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland","institution_ids":["https://openalex.org/I4404532900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013803774"],"corresponding_institution_ids":["https://openalex.org/I4404532900"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.9624,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.86535868,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"95","issue":"3","first_page":"303","last_page":"310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.6480000019073486},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.7059999704360962},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7910000085830688},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.9620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.847000002861023},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.4090000092983246},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8230000138282776},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.9509999752044678},{"id":"https://openalex.org/keywords/reinduction-chemotherapy","display_name":"reinduction chemotherapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7649999856948853},{"id":"https://openalex.org/keywords/high-dose-cytarabine","display_name":"high-dose cytarabine","score":0.9819999933242798},{"id":"https://openalex.org/keywords/best-supportive-care","display_name":"best supportive care","score":0.8050000071525574},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.7250000238418579},{"id":"https://openalex.org/keywords/southern-switzerland","display_name":"southern Switzerland","score":0.8410000205039978},{"id":"https://openalex.org/keywords/italian-speaking-switzerland","display_name":"Italian-speaking Switzerland","score":0.7070000171661377},{"id":"https://openalex.org/keywords/curative-intent","display_name":"curative intent","score":0.33000001311302185},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.8334375619888306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45971065759658813},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4465397298336029},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4299788177013397},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3902786374092102},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3500196635723114},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30959177017211914},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.15163713693618774}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010166","descriptor_name":"Palliative Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013557","descriptor_name":"Switzerland","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/030089160909500306","doi":"https://doi.org/10.1177/030089160909500306","is_oa":false,"landing_page_url":"https://doi.org/10.1177/030089160909500306","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},{"id":"pmid:19688968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19688968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1484199726","https://openalex.org/W1492445977","https://openalex.org/W1492609361","https://openalex.org/W1519562949","https://openalex.org/W1556454749","https://openalex.org/W1821176711","https://openalex.org/W1834277939","https://openalex.org/W1929561528","https://openalex.org/W1963335440","https://openalex.org/W1972166092","https://openalex.org/W1972221279","https://openalex.org/W1980062470","https://openalex.org/W2006691924","https://openalex.org/W2018546973","https://openalex.org/W2023836032","https://openalex.org/W2058463377","https://openalex.org/W2063602823","https://openalex.org/W2070012795","https://openalex.org/W2077293974","https://openalex.org/W2081688598","https://openalex.org/W2087075929","https://openalex.org/W2089922853","https://openalex.org/W2094609236","https://openalex.org/W2097035477","https://openalex.org/W2109065151","https://openalex.org/W2136781769","https://openalex.org/W2148921332","https://openalex.org/W2162700652","https://openalex.org/W2167228936","https://openalex.org/W2182311866","https://openalex.org/W2202212559","https://openalex.org/W2331849216","https://openalex.org/W2401349765","https://openalex.org/W2414419475","https://openalex.org/W2461234028","https://openalex.org/W4302772633"],"related_works":["https://openalex.org/W2316850199","https://openalex.org/W2056968762","https://openalex.org/W2325902709","https://openalex.org/W1993631490","https://openalex.org/W1936436543","https://openalex.org/W2586167070","https://openalex.org/W4298329783","https://openalex.org/W2061912186","https://openalex.org/W2046185040","https://openalex.org/W2060191608"],"abstract_inverted_index":{"AIMS":[0],"AND":[1,34],"BACKGROUND:":[2],"To":[3],"evaluate":[4],"the":[5,17,77,160,222,235,324,338,405,423],"outcome":[6,322,398],"of":[7,20,38,72,127,221,300,323,337,425],"adult":[8,40,78],"patients":[9,41,137,162,184,223,236,302,325,386],"with":[10,43,122,164,238,291,304,387],"de":[11],"novo":[12],"acute":[13,44,73,388],"myeloid":[14,45,74,389],"leukemia":[15,46,75,390],"in":[16,76,80,153,244,258,270,422],"Italian-speaking":[18],"part":[19],"Switzerland":[21,82],"and":[22,30,57,64,89,92,189,207,218,361,380,396,417],"to":[23,28,50,62,108,131,298,371,382],"identify":[24],"prognostic":[25,374],"factors,":[26],"time":[27,61,130,381],"progression":[29,63,132],"overall":[31,65,117,125,378],"survival.":[32],"METHODS":[33],"STUDY":[35],"DESIGN:":[36],"Data":[37],"all":[39],"diagnosed":[42],"from":[47],"January":[48],"1984":[49],"December":[51],"2003":[52],"were":[53,67,95,142,169,225,242,369],"collected":[54],"retrospectively.":[55],"Univariate":[56],"multivariate":[58,343],"analysis":[59,344],"for":[60,97,183,191,376],"survival":[66,118,126,152,201,311,379],"performed.":[68],"RESULTS:":[69],"The":[70,100,110,150,174,213,321],"incidence":[71],"population":[79],"southern":[81],"is":[83,399,407],"2.6/100,000":[84],"per":[85],"year.":[86],"Complete":[87],"clinical":[88,246,427],"pathological":[90],"data":[91],"follow-up":[93,112],"information":[94],"available":[96],"128":[98],"patients.":[99],"median":[101,111,151,249],"age":[102,250,350],"was":[103,113,119,133,156,181,205,216,251,329],"67":[104],"years":[105,188,196,204,264],"(range,":[106],"18":[107],"94).":[109],"97":[114],"months.":[115,135,158],"Median":[116,129],"6":[120,287],"months,":[121],"a":[123,165,230,245,259,271,274,305,309,426],"2-year":[124],"16%.":[128],"3":[134],"Thirty-five":[136],"(median":[138,283],"age,":[139],"80":[140],"years)":[141],"given":[143,226,314,363],"best":[144],"supportive":[145],"care":[146],"and/or":[147],"palliative":[148],"chemotherapy.":[149],"this":[154],"subset":[155],"2":[157,203],"Of":[159,234],"93":[161,301],"treated":[163,237,243,269,282,290,303,326,340,421],"curative":[166,239,306],"intent,":[167,240],"48":[168],"older":[170,193,392],"than":[171,186,194,254,278,312,335,393],"60":[172,187,195,394],"years.":[173],"complete":[175,232],"remission":[176],"rate":[177,215],"after":[178,327],"induction":[179],"chemotherapy":[180,228],"80%":[182],"younger":[185,403],"31%":[190],"those":[192,255,279,313],"(P":[197,210,265,318,332,351,358,366],"<":[198,211,266,319],"0.0001).":[199],"Overall":[200],"at":[202],"40%":[206],"12%,":[208],"respectively":[209],"0.0005).":[212,320],"relapse":[214],"61%,":[217],"only":[219,349],"28%":[220],"who":[224],"reinduction":[227],"reached":[229],"second":[231],"remission.":[233],"52%":[241],"trial.":[247,428],"Their":[248],"significantly":[252,275,330],"lower":[253],"not":[256,280],"included":[257],"trial:":[260],"57":[261],"vs":[262,286],"66":[263],"00001).":[267],"Patients":[268,289],"trial":[272],"had":[273,308],"better":[276,310,331,408],"prognosis":[277,406],"so":[281],"survival,":[284],"12":[285],"months).":[288],"high-dose":[292,412],"cytarabine":[293,316,413],"as":[294,414],"first-line":[295],"therapy":[296,416],"(given":[297],"25":[299],"intent)":[307],"standard":[315],"doses":[317],"1993":[328,365],"=":[333,352,359,367],"0.026)":[334],"that":[336],"previously":[339],"cohort.":[341],"In":[342],"(not":[345],"including":[346],"cytogenetic":[347],"data),":[348],"0.005),":[353],"performance":[354],"status":[355],">":[356],"1":[357],"0.001)":[360],"treatment":[362],"before/after":[364],"0.044)":[368],"found":[370],"be":[372],"independent":[373],"factors":[375],"both":[377],"progression.":[383],"CONCLUSIONS:":[384],"Most":[385],"are":[391,420],"years,":[395],"their":[397],"still":[400],"disappointing.":[401],"For":[402],"patients,":[404],"if":[409,418],"they":[410,419],"receive":[411],"post-remission":[415],"setting":[424]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}